Technology
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.
The deal is expected to close in the second quarter of 2021. It will value the combined company at approximately $1.1 billion.
The Kepler Night Nurse Edge Box uses vision technology to allow staff to monitor patients and respond to physical distress.
Also: Valo Health closes $300 million for machine learning drug discovery; Blue Note Therapeutics supports its in-development prescription DTx with $26.25 million.
The company is launching the Fitbit Ace 3 for $79.99.
The digital MSK company is looking to bundle the non-invasive, non-addictive pain reduction device alongside the rest of its employer-focused offerings.
The study looks at menstruation symptoms and features from over 10,000 participants.
The joint venture will enable the companies to collaborate through a virtual platform and physical base in Paris.
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.